The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mohit Jaju
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Godavari Drugs Ltd has informed the stock exchange about a disclosure received under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, filed by Mohit Jaju. This regulation typically applies when a promoter or person holding more than 2% shares reports the creation, release, or invocation of a pledge or other encumbrance on their shares. The full details of the disclosure (including number of shares, percentage, and nature of encumbrance) are not available in the document retrieved, as the BSE page returned an error. Investors should check the exchange's corporate announcements section directly for the complete filing.
No immediate price impact can be assessed without the actual disclosure details. If this involves a new pledge on promoter shares, it could be a negative signal; if it's a pledge release or invocation, the implications differ. Shareholders should look up the full disclosure on the BSE/NSE portal before drawing conclusions.